1. Repository of OAI
Ελληνικά   English  

Browsing by Author Pavlidis, N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 155 to 174 of 317 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literatureKamposioras, K.; Pentheroudakis, G.; Pectasides, D.; Pavlidis, N.24-Nov-2015-
Management of leptomeningeal malignancyPentheroudakis, G.; Pavlidis, N.24-Nov-2015-
The masterclass of the european school of oncology: the 'key educational event' of the schoolPavlidis, N.; Gatzemeier, W.; Popescu, R.; Stahel, R.; Pinedo, H.; Cavalli, F.; Costa, A.24-Nov-2015-
Matrix metalloproteinases in carcinoma of unknown primaryKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015-
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) studySkarlos, D. V.; Fountzilas, G.; Pavlidis, N.; Beer, M.; Makrantonakis, P.; Aravantinos, G.; Pantelakos, P.; Tsavaris, N.; Karpasitis, N.; Kosmidis, P.24-Nov-2015-
Megestrol activity in recurrent adult type granulosa cell tumour of the ovaryBriasoulis, E.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenPentheroudakis, G.; Fountzilas, G.; Bafaloukos, D.; Koutsoukou, V.; Pectasides, D.; Skarlos, D.; Samantas, E.; Kalofonos, H. P.; Gogas, H.; Pavlidis, N.24-Nov-2015-
Metastatic breast carcinoma confined to bone: portrait of a clinical entityBriasoulis, E.; Karavasilis, V.; Kostadima, L.; Ignatiadis, M.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Metastatic involvement of placenta and foetus in pregnant women with cancerPavlidis, N.; Pentheroudakis, G.24-Nov-2015-
Metronomic oral vinorelbine (MOVIN): a dose establishing translational and pharmacokinetic study in patients with metastatic refractory cancerBriasoulis, E.; Tolis, C.; Pappas, P.; Marselos, M.; Nicolaides, C.; Nikiforidis, L.; Nikolaidou, M.; Siarabi, O.; Tzamakou, E.; Pavlidis, N.24-Nov-2015-
Metronomic Oral Vinorelbine in Patients with Recurrent Breast, Prostate or Non-Small Cell Lung Cancer: Optimal Dose-Finding Trial of the Hellenic Cooperative Oncology GroupBriasoulis, E.; Kalofonos, H.; Samantas, E.; Varthalitis, I.; Syrigos, K. N.; Fountzilas, G.; Pappas, P.; Sainis, I.; Puozzo, C.; Pavlidis, N.24-Nov-2015-
The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancerKostadima, L.; Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-
Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancerSmith, I. E.; Stuart-Harris, R.; Pavlidis, N.; Bozek, T.24-Nov-2015-
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature reviewPentheroudakis, G.; Greco, F. A.; Pavlidis, N.24-Nov-2015-
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009Van Cutsem, E.; Dicato, M.; Arber, N.; Berlin, J.; Cervantes, A.; Ciardiello, F.; De Gramont, A.; Diaz-Rubio, E.; Ducreux, M.; Geva, R.; Glimelius, B.; Glynne Jones, R.; Grothey, A.; Gruenberger, T.; Haller, D.; Haustermans, K.; Labianca, R.; Lenz, H. J.; Minsky, B.; Nordlinger, B.; Ohtsu, A.; Pavlidis, N.; Rougier, P.; Schmiegel, W.; Van de Velde, C.; Schmoll, H. J.; Sobrero, A.; Tabernero, J.24-Nov-2015-
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyBriasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N.24-Nov-2015-
Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groupsMcLeod, H. L.; Murray, L. S.; Wanders, J.; Setanoians, A.; Graham, M. A.; Pavlidis, N.; Heinrich, B.; ten Bokkel Huinink, W. W.; Wagener, D. J.; Aamdal, S.; Verweij, J.24-Nov-2015-
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group studyEconomopoulos, T.; Papageorgiou, S.; Rontogianni, D.; Kaloutsi, V.; Fountzilas, G.; Tsatalas, C.; Pavlidis, N.; Pectasides, D.; Papageorgiou, E.; Dimopoulos, M.24-Nov-2015-
Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancerMauri, D.; Polyzos, N. P.; Salanti, G.; Pavlidis, N.; Ioannidis, J. P.24-Nov-2015-
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological studyBriasoulis, E.; Agnantis, N. J.; Zagorianakou, P.; Kamina, S.; Gorezi, M.; Pavlidis, N.; Bai, M.24-Nov-2015-
Showing results 155 to 174 of 317 < previous   next >